W. L. Gore & Associates, Inc. (Gore) has received CE mark for the 23 mm and 27 mm diameter sizes of the contralateral leg component of the GORE® EXCLUDER® AAA Endoprosthesis for treatment of abdominal aortic aneurysm (AAA). The new diameter devices provide physicians with the ability to repair AAAs in a wider range of anatomies eligible for minimally invasive endovascular AAA repair.
In a recent study it has been found that cholesterol therapy using multiple drugs over an extended period may be more effective than taking a single statin medication. In previous studies the benefits of using a combination of two or three drugs aimed to aggressively lower LDL (bad cholesterol) and raise HDL (good cholesterol) have been mentioned. This is the first one to show long term benefits over a period of 20 years.
Aptus Endosystems has announced closing on US$25 million of equity financing. Synergy Life Science Partners, a new investor, led the round and was joined by existing investors US Venture Partners and Longitude Capital Management. Mudit K Jain, partner at Synergy Life Science Partners will join the company s Board of Directors.
New guidance published on 27 June 2012 by the UK National Institute for Health and Clinical Excellence (NICE) aims to reduce the current high toll of long-term ill health or death caused by venous thromboembolic diseases by clarifying for the first time what combination of tests and treatments results in the most clinically and cost effective diagnosis and management of the conditions.
Flexible Stenting Solutions, Inc. (“FSS”), a leading developer of next generation peripheral arterial, venous, neurovascular and biliary stents, announced today that it has extended its CE Mark authorized family of peripheral vascular stents to include the FlexStent® Iliac Self Expanding Stent System.
Clinical investigators are for the first time examining the retrograde tibiopedal interventional approach, an endovascular technique that has the potential to reduce the rate of leg amputations by as much as 50% in patients with critical limb ischaemia. Cook Medical is sponsoring the Tibiopedal Access for Crossing Infrainguinal Artery Occlusions study.
Medtronic, Inc. (NYSE: MDT) announced today that a judge in the Eastern District Court of Virginia last week ruled in Medtronic s favor in a patent case brought by W.L Gore & Associates, Inc.
Covidien announced the launch of its 1 in 1,000 campaign to help educate women about the risk of pregnancy-related blood clots, one of the leading causes of maternal mortality in the developed world. The announcement was made at the 2012 annual meeting of the Association of Women s Health, Obstetric and Neonatal Nurses
With the University of Pittsburgh s development of a cell-free, biodegradable artery graft comes a potentially transformative change in coronary artery bypass surgeries: Within 90 days after surgery, the patient will have a regenerated artery with no trace of synthetic graft materials left in the body.
There has been a three-fold increase in the number of patients receiving acute dialysis because of injury after cardiac and vascular surgeries since 1995, states a new study in CMAJ (Canadian Medical Association Journal).
Acute kidney injury appears to be an increasing problem in cardiac and vascular surgeries, researchers found. Severe cases marked by need for acute dialysis after major elective surgery -- although rare -- rose year over year from a rate of 0.2% in 1995 to 0.6% in 2009, Amit X. Garg, MD, PhD, of Western University in London, Ontario, and colleagues reported.
The US Food and Drug Administration (FDA) recently selected an investigational stent graft for endovascular treatment of thoracic aortic aneurysms involving branch vessel. The device would be used inan early feasibility pilot programme.
Regulatory Agency Selects Investigational Medical Device for Endovascular Treatment of Thoracic Aortic Aneurysms Involving Branch Vessel for Early Feasibility Pilot Program
The UNC Center for Heart & Vascular Care’s Aortic Disease Management team is the first in the USA to use a new FDA-approved device to successfully treat a complex abdominal aortic aneurysm (AAA).
The Sandwich Technique, developed to overcome current anatomical and device constraints, could expand the limits of endovascular aneurysm repair (EVAR) in a safe, easy to perform, and cost-effective manner, Armando Lobato, ICVE, Sao Paulo Vascular & Endovascular Surgery Institute, Beneficencia Portuguesa Hospital, Sao Paulo, Brazil, told delegates at the Society for Vascular Surgery Annual Meeting in Washington DC, USA.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos